Inhibition of caspase-1 has been shown to effectively ameliorate cognitive impairment in AD mice [193], suggesting that caspase-1 inhibitors have potentials to be used for neurodegenerative diseases. This evidence concerns the gene CASP1 and Cognitive impairment.